Effect of Administration of Moxifloxacin plus Rifampin against Mycobacterium tuberculosis for 7 of 7 Days versus 5 of 7 Days in an In Vitro Pharmacodynamic System

por Drusano, G. L., Sgambati, N., Eichas, A., Brown, D., Kulawy, R., Louie, A.
Publicado 2011

The Combination of Rifampin plus Moxifloxacin Is Synergistic for Suppression of Resistance but Antagonistic for Cell Kill of Mycobacterium tuberculosis as Determined in a Hollow-Fi...

por Drusano, G. L., Sgambati, Nicole, Eichas, Adam, Brown, David L., Kulawy, Robert, Louie, Arnold
Publicado 2010

Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents

por Rizk, M. L., Bhavnani, S. M., Drusano, G., Dane, A., Eakin, A. E., Guina, T., Jang, S. H., Tomayko, J. F., Wang, J., Zhuang, L., Lodise, T. P.
Publicado 2019